216 results
Page 3 of 11
8-K
EX-99.1
2xsy9h4yijz
12 Nov 21
TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O’Dowd, as Chief Executive Officer
6:47am
SC TO-I
EX-99
6m4kr9ghzq
26 Aug 21
Issuer tender offer statement
4:55pm
8-K
EX-99.1
gqp 5w6xkv
9 Aug 21
TherapeuticsMD Announces Appointment of Hugh O’Dowd as President
4:35pm
8-K
EX-99.2
rlqjtq3vdh13
4 Aug 21
TherapeuticsMD Announces Second Quarter 2021 Financial Results
7:00am
8-K
EX-99.2
hjvorh
6 May 21
TherapeuticsMD Announces First Quarter 2021 Financial Results
7:00am
8-K
EX-99.1
azlvhnw41yk y6fvkxt1
6 May 21
TherapeuticsMD Announces First Quarter 2021 Financial Results
7:00am
S-3ASR
7b0iaa8 33os
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-99.2
2puy5qs yz6i8
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
424B2
cc070v8f9lizoww emt
16 Feb 21
Prospectus for primary offering
6:17am
424B5
wmpafljnwuckwz
10 Feb 21
Prospectus supplement for primary offering
5:11pm
8-K
EX-99.1
kqtbupxl28mpm0s rfdi
13 Jan 21
Entry into a Material Definitive Agreement
8:50am
424B5
hw0xos zx
27 Nov 20
Prospectus supplement for primary offering
4:46pm
424B2
wuu8f84y
12 Nov 20
Prospectus for primary offering
5:18pm
424B5
tzydvf 45hy3koutb
9 Nov 20
Prospectus supplement for primary offering
5:27pm